Market revenue in 2022 | USD 30.0 million |
Market revenue in 2030 | USD 53.4 million |
Growth rate | 7.5% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 39% in 2022. Horizon Databook has segmented the Spain sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
In Spain, the sepsis diagnostics market is driven by several key factors, including increasing awareness of sepsis, advancements in diagnostic technologies, and the growing need for improved patient outcomes.
The growing recognition of sepsis as a critical health issue has led to a heightened focus on early detection and precise diagnostics. Spain’s healthcare system has been progressively adopting advanced diagnostic tools to address the high prevalence of sepsis.
The Spanish Society of Intensive Care, Critical Medicine, and Coronary Units reports that sepsis affects a substantial number of patients annually, with a considerable proportion of cases caused due to HAIs.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account